CardiologyBeginner

ORBIT Bleeding Risk Score for Anticoagulation in Atrial Fibrillation

Calculates the 5-item ORBIT bleeding score to stratify major hemorrhage risk on DOACs or Warfarin.

Clinical Parameters

5 Variables

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
Advertisement
High Yield Prometric TopicCardiology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like ORBIT Bleeding Risk Score for Anticoagulation in Atrial Fibrillation frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the ORBIT Bleeding Risk Score for Anticoagulation in Atrial Fibrillation?

📋Clinical Summary & Definition Capsule

The ORBIT Bleeding Risk Score for Anticoagulation in Atrial Fibrillation is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. Implements the ORBIT risk score (Older age ≥ 74, Reduced renal function, Bleeding history, Insufficient hemoglobin/anemia, Treatment with antiplatelets) validated in the ORBIT-AF and ROCKET-AF trials to guide safe oral anticoagulation in atrial fibrillation. Clinical scoring tools like ORBIT Bleeding Risk Score for Anticoagulation in Atrial Fibrillation are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

A simpler, more accurate bleeding score than HAS-BLED in contemporary DOAC-treated atrial fibrillation populations.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate ORBIT Bleeding Risk Score for Anticoagulation in Atrial Fibrillation:

ORBIT Score = Older age ≥74 (1) + Renal eGFR <60 (1) + Bleeding history (2) + Insufficient Hgb/Anemia (2) + Antiplatelet treatment (1)
Range: 0 to 7 points
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 2Low Bleeding Risk (Score 0–2: 2.4 Major Bleeds per 100 Pt-Yrs / Anticoagulate)green
3 – 3Medium Bleeding Risk (Score 3: 4.7 Major Bleeds per 100 Pt-Yrs / Close Monitoring)yellow
≥ 4High Bleeding Risk (Score 4–7: 8.1 Major Bleeds per 100 Pt-Yrs / Address Modifiable Factors)red
Clinical Limitations & Contraindications

When to Exercise Caution

Calculates baseline annual major bleeding risk; does not predict minor superficial bruising or localized epistaxis.

Sponsored Content
Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-08-08

Peer-Reviewed Medical Literature

  • O'Brien EC, et al. The ORBIT bleeding score: a simple score to predict major bleeding in patients with atrial fibrillation. Eur Heart J. 2015;36(46):3258-3264.
  • Lip GYH, et al. Comparative validation of the HAS-BLED and ORBIT scores for predicting major bleeding in patients with atrial fibrillation. Am J Med. 2017;130(5):579-583.
Advertisement